Ninth Circuit Upholds Oregon Prescription Drug Transparency Act
- August 29, 2025
A divided Ninth Circuit panel rejected the Pharmaceutical Research and Manufacturers of America’s (PhRMA’s) constitutional challenge to an Oregon statute that requires drug makers to report to the state pricing and other information about certain prescription drugs.
ARTICLE TAGS
You must be logged in to access this content.